MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hemifacial spasm(HFS)"

  • 2018 International Congress

    Assessing hemifacial spasm: The HFSG scale

    S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…
  • 2018 International Congress

    Effect of Cold Compression Before Botulinum Neurotoxin Injection in Hemifacial Spasm

    P. Dhanachanvisith, T. Tantirittisak (Bangkok, Thailand)

    Objective: To compare effect of cold compression and no cold compression before Botulinum neurotoxin (BoNT) injection on severity, frequency of hemifacial spasm (HFS) and complication…
  • 2018 International Congress

    Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study

    A. Suengtaworn, Y. Pitakpatapee, P. Soontrapa, C. Hurst, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics, along with the treatment outcomes of botulinum neurotoxin (BoNT) between HFS patients with and without the BBK-2 sign as…
  • 2018 International Congress

    The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients

    Y. Pitakpatapee, A. Suengtaworn, P. Soontrapa, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics and treatment outcomes after injection of botulinum neurotoxin (BoNT) type A between non-troublesome and troublesome hemifacial spasm (HFS) in…
  • 2017 International Congress

    What does the severity of hemifacial spasm mean to us?

    J. Youn, J.W. Cho (Seoul, Republic of Korea)

    Objective: We investigated the clinical meaning of the severity of hemifacial spasm (HFS) in the patients who performed microvascular decompression (MVD). Background: Even though the most…
  • 2017 International Congress

    Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm

    S. Pandey, S. Jain (New Delhi, India)

    Objective: To study demographic and clinical features of  primary and secondary hemifacial spasm and assess their response to botulinum toxin therapy. Background: Hemifacial spasm (HFS)…
  • 2017 International Congress

    Unusual facial synkinesia after Bell’s palsy: interactive Marin-Amat syndrome proven by surface electromyogram, successfully treated with low dose botulinum toxin A.

    H. Mori (Kurashiki, Japan)

    Objective: To clarify unusal facial synkinesia by using surface electromyogram and botulinum toxin A. Background: Marin-Amat syndrome is a facial synkinesis manifesting as involuntary eyelid…
  • 2017 International Congress

    The clinical and neuroimaging analysis in hemifacial spasm with associated cranial neuropathy: retrospective case series study

    Y.-Y. Chang, Y.-F. Chen, Y.-F. Chen, M.-Y. Lan, J.-S. Liu (Kaohsiung, Taiwan)

    Objective: To evaluate the clinical characteristics and neuroimaging findings observed in the association between hemifacial spasms (HFS) and other cranial neuropathy in a cohort of…
  • 2017 International Congress

    Differences between Hemifacial spasm with or without neurovascular conflict. Therapeutic implications with botulinum toxin type A.

    J.S. Bestoso, L. Ciancaglini, C. Stefani, C. Azcona, M.L. Contartese, A. Pappolla, J.I. Rojas, D. Bauso (Buenos Aires, Argentina)

    Objective: To evaluate the presence of possible clinical differences between patients with HS with and without neurovascular conflict (NVC +, NVC-) and their therapeutic response…
  • 2017 International Congress

    Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

    O. Dogu, H. Kalegasi (Mersin, Turkey)

    Objective: To assess the frequency of Babinski-2 sign among patients with hemifacial spasm (HFS). Background: The Babinski-2 sign (“the other” Babinski sign, “brow-lift sign”), is…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley